Appraisal 111

 

NICE (Multiple) Technology Appraisal Guidance No 111

http://www.nice.org.uk/guidance/TA111
 

This guidance has been updated and replaced by TA217 Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease

Published Date: 22 November 2006

Evidence

Reviewed for Scotland

This guidance has been assessed according to our procedure for reviewing the applicability of NICE MTA guidance for NHSScotland. 

Read our process for reviewing NICE guidance